Previously recorded as Daiichi Pure Chemicals Co., Ltd. (to 2008)
125 patents currently held
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Aug 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
23
Ending by 2030
Aug 2027
Next term end
116
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Nov 2034 · High confidence
Also notable
Ends Aug 2036 · High confidence
Also notable
Ends Oct 2032 · High confidence
Also notable
Ends Aug 2033 · High confidence
Also notable
Ends Jun 2037 · High confidence
Also notable
Ends Mar 2035 · High confidence
Also notable
Ends Nov 2038 · High confidence
Also notable
Ends Aug 2033 · High confidence
Gradient Liquid Feed Device for Sample Analyzer
US 9,970,908
Cited by 14 later US patents, top 25% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2034.
Benzyl Compound
US 10,822,357
Cited by 9 later US patents, top 25% of utility patents granted in 2020 in our data. Protection runs to 2036.
Immunochromatographic Test Device
US D800,320
Granted 2017. Computed term ends 2032.
Immunochromatographic Test Strip and Detection Method Using Immunochromatography for Detecting Object in Red Blood Cell-Containing Sample
US 9,885,707
Granted 2018 and renewed at every maintenance window due so far. Protection runs to 2033.
Novel Diphenylmethane Protective Agent
US 10,851,120
Granted 2020. Computed term ends 2037.
Method for Determining Prognosis of Renal Cell Carcinoma
US 10,190,172
Granted 2019. Computed term ends 2035.
Novel Alkyldiphenylmethane Protective Agent
US 10,870,667
Granted 2020. Computed term ends 2038.
Pivka-II Measurement Method, Measurement Reagent, and Measurement Kit
US 10,539,559
Granted 2020. Computed term ends 2033.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 18, 2027The maintenance fee for Method for Detecting Gene Mutation (US 11,702,688) comes due Jan 18, 2027. Unpaid by Jul 19, 2027, it lapses early.
- 4 fees due Feb 4 to 20, 2027 · next Feb 4
- 4 fees due Mar 17 to 24, 2027 · next Mar 17
- 1 fee due Apr 27, 2027The maintenance fee for Antibody to N-Terminal Region of Hemoglobin Beta-Chain (US 9,169,320) comes due Apr 27, 2027. Unpaid by Oct 27, 2027, it lapses early.
- 1 fee due Jun 17, 2027The maintenance fee for New Xanthene Protective Agent (US 10,508,124) comes due Jun 17, 2027. Unpaid by Dec 17, 2027, it lapses early.
- 2 fees due Jul 9 to 21, 2027 · next Jul 9
- 2 fees due Aug 4 to 16, 2027 · next Aug 4
- 1 fee due Sep 3, 2027The maintenance fee for Container for Specimen Dilution (US 10,576,472) comes due Sep 3, 2027. Unpaid by Mar 3, 2028, it lapses early.
- 5 fees due Oct 5 to 21, 2027 · next Oct 5
- 1 fee due Nov 17, 2027The maintenance fee for Method for Pre-Treating Sample Containing Glycated Hemoglobin (US 9,341,633) comes due Nov 17, 2027. Unpaid by May 17, 2028, it lapses early.
Recent changes
- 5 of the patents on this record were granted since Aug 23, 2026
What they patent
The largest of its 116 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D688,796 | Cap for a Blood Collection Tube In force · High confidence | In force | High confidence | |
| US 7,951,553 | Method of Assaying Glycated Protein In force · High confidence | In force | High confidence | |
| US 8,026,107 | Agglutination Inhibition Assay Method and Reagent In force · High confidence | In force | High confidence | |
| US 8,987,005 | Reagent for Measuring Agglutination and Method of Measuring Agglutination In force · High confidence | In force | High confidence | |
| US D719,670 | Liquid Chromatograph In force · High confidence | In force | High confidence | |
| US D719,671 | Liquid Chromatograph In force · High confidence | In force | High confidence | |
| US 9,261,443 | Method for Quantification of Soluble LR 11 In force · High confidence | In force | High confidence | |
| US D734,484 | Liquid Chromatograph In force · High confidence | In force | High confidence | |
| US D739,006 | Sample Dilution Container In force · High confidence | In force | High confidence | |
| US D740,408 | Collection Tool In force · High confidence | In force | High confidence |
Also on record, not counted in the 125: 5 patents in force now held by others · 66 patents ended · 79 applications pending · 136 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.